Published in:
Open Access
01-12-2021 | Surgery | Research
Looking for a strategy in treating peritoneal gastric cancer carcinomatosis: an Italian multicenter Gastric Cancer Research group’s analysis
Authors:
Luigina Graziosi, Elisabetta Marino, Maria Bencivenga, Alessia D’Ignazio, Leonardo Solaini, Silvia Ministrini, Michela Caprioli, Michele Sacco, Daniele Marrelli, Gianni Mura, Maurizio Degiuli, Paolo Morgagni, Guido Alberto Massimo Tiberio, Giovanni De Manzoni, Franco Roviello, Annibale Donini
Published in:
World Journal of Surgical Oncology
|
Issue 1/2021
Login to get access
Abstract
Background
The present study provides a snapshot of Italian patients with peritoneal metastasis from gastric cancer treated by surgery in Italian centers belonging to the Italian Research Group on Gastric Cancer. Prognostic factors affecting survival in such cohort of patients were evaluated with the final aim to identify patients who may benefit from radical intent surgery.
Methods
It is a multicentric retrospective study based on a prospectively collected database including demographics, clinical, surgical, pathological, and follow-up data of patients with gastric cancer and synchronous macroscopic peritoneal metastases. Patients were surgically treated from January 2005 to January 2017. We focused on patients with macroscopic peritoneal carcinomatosis (PC) treated with upfront surgery in order to provide homogeneous evidences.
Results
Our results show that patients with peritoneal carcinomatosis cannot be considered all lost. Strictly selected cases (R0/R1 and P1 patients) could benefit from an aggressive surgical approach performing an extended lymphadenectomy and HIPEC treatment.
Conclusion
The main result of the study is that GC patients with limited peritoneal involvement can have a survival benefit from a surgery with “radical oncological intent”, that means extended lymphadenectomy and R0 resection. The retrospective nature of this study is an important bias, and for this reason, we have started a prospective multicentric study including Italian stage IV patients that hopefully will give us more answers.